Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Exxon Mobil | 3.48% | $2.63M | $635.44B | 34.79% | 74 Outperform | |
| Johnson & Johnson | 2.77% | $2.10M | $590.40B | 54.63% | 78 Outperform | |
| Micron | 2.63% | $1.99M | $473.78B | 304.49% | 79 Outperform | |
| Bank of America | 2.03% | $1.54M | $384.86B | 16.49% | 72 Outperform | |
| Merck & Company | 1.70% | $1.29M | $301.96B | 38.98% | 80 Outperform | |
| Chevron | 1.55% | $1.17M | $370.23B | 16.37% | 71 Outperform | |
| AbbVie | 1.48% | $1.12M | $404.24B | 11.68% | 66 Neutral | |
| UnitedHealth | 1.45% | $1.10M | $261.06B | -43.60% | 72 Outperform | |
| Wells Fargo | 1.37% | $1.04M | $273.88B | 10.22% | 80 Outperform | |
| Citigroup | 1.19% | $902.60K | $208.04B | 42.06% | 68 Neutral |